Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Moffat

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
Nature Structural & Molecular Biology|December 9, 2022
A cohesin traffic pattern genetically linked to gene regulationAnne-Laure Valton, Sergey V Venev, Barbara Mair, et al.
Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.
Cancer Research|April 26, 2018
The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer ImmunosurveillanceMiho Tanaka, Jason H Fine, Christina L Kirkham, et al.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Transcription|January 11, 2012
Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1BZuyao Ni, Jonathan B Olsen, Xinghua Guo, et al.
American Journal of Physiology. Renal Physiology|October 1, 2019
Forward genetic screen in human podocytes identifies diphthamide biosynthesis genes as regulators of adhesionDavide P Cinà, Troy Ketela, Kevin R Brown, et al.
Stem Cell Reports|January 17, 2025
Selective activation of FZD2 and FZD7 reveals non-redundant function during mesoderm differentiationRony Chidiac, Andy Yang, Elli Kubarakos, et al.
Neuro-Oncology Advances|November 16, 2022
Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignanciesNicholas Mikolajewicz, Shahbaz Khan, Mara Trifoi, et al.
Current Drug Discovery Technologies|May 25, 2013
A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell linesMiliana Vojvodic, Loen M Hansford, Olena Morozova, et al.
Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
Nature Structural & Molecular Biology|December 9, 2022
A cohesin traffic pattern genetically linked to gene regulationAnne-Laure Valton, Sergey V Venev, Barbara Mair, et al.
Oncogene|November 8, 2019
A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cellsBranavan Manoranjan, Chirayu Chokshi, Chitra Venugopal, et al.
Cancer Research|April 26, 2018
The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer ImmunosurveillanceMiho Tanaka, Jason H Fine, Christina L Kirkham, et al.
Scientific Reports|October 16, 2025
CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastomaNeil Savage, Etienne Danis, Chirayu R Chokshi, et al.
Transcription|January 11, 2012
Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1BZuyao Ni, Jonathan B Olsen, Xinghua Guo, et al.
American Journal of Physiology. Renal Physiology|October 1, 2019
Forward genetic screen in human podocytes identifies diphthamide biosynthesis genes as regulators of adhesionDavide P Cinà, Troy Ketela, Kevin R Brown, et al.
Stem Cell Reports|January 17, 2025
Selective activation of FZD2 and FZD7 reveals non-redundant function during mesoderm differentiationRony Chidiac, Andy Yang, Elli Kubarakos, et al.
Neuro-Oncology Advances|November 16, 2022
Leveraging the CSF proteome toward minimally-invasive diagnostics surveillance of brain malignanciesNicholas Mikolajewicz, Shahbaz Khan, Mara Trifoi, et al.
Current Drug Discovery Technologies|May 25, 2013
A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell linesMiliana Vojvodic, Loen M Hansford, Olena Morozova, et al.
Frontiers in Immunology|July 25, 2022
Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid TumorsNazanin Tatari, Xiaoyu Zhang, Shawn C Chafe, et al.
Pageof 20